Archimedes Tech SPAC Partners III Co. Finalizes IPO, Secures $276M in Trust Account
summarizeSummary
Archimedes Tech SPAC Partners III Co. announced the successful closing of its Initial Public Offering and a concurrent private placement, depositing $276 million into a trust account to pursue a business combination.
check_boxKey Events
-
IPO Consummation Confirmed
The company finalized its Initial Public Offering of 27,600,000 units at $10.00 per unit, including the full exercise of the over-allotment option, generating gross proceeds of $276,000,000.
-
Concurrent Private Placement Completed
A simultaneous private placement of 762,000 private units at $10.00 per unit generated an additional $7,620,000 in gross proceeds.
-
Trust Account Fully Funded
A total of $276,000,000 from the net proceeds of the IPO and private placement was deposited into a trust account for the benefit of public shareholders.
-
Post-IPO Balance Sheet Disclosed
The filing includes a balance sheet as of January 26, 2026, reflecting the company's financial position immediately following the IPO and private placement.
auto_awesomeAnalysis
This 8-K filing provides comprehensive details and a balance sheet following the consummation of Archimedes Tech SPAC Partners III Co.'s Initial Public Offering (IPO) and a concurrent private placement. While the IPO closing was previously disclosed on January 22, 2026, this filing adds material financial information, including the full exercise of the underwriters' over-allotment option and the deposit of $276 million into the trust account. For a SPAC, successfully completing its IPO and fully funding the trust account is a critical milestone, providing the necessary capital base to pursue its intended business combination. The pricing at $10.00 per unit, consistent with the current trading near 52-week highs, indicates a stable and well-received capital raise.
At the time of this filing, ARCIU was trading at $10.10 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $278.8M. The 52-week trading range was $10.07 to $10.15. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.